Viewing Study NCT03772561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-01-27 @ 3:38 AM
Study NCT ID: NCT03772561
Status: RECRUITING
Last Update Posted: 2025-07-22
First Post: 2018-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies
Sponsor: National University Hospital, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD5363 View
None Olaparib View
None Durvalumab View
None Solid Tumor View